The invention further comprises a pharmaceutical composition comprising an antibody of the invention or an antigen binding fragment thereof, a nucleic acid molecule of the invention, or {HEAD ~ an immunogenic polypeptide} of the invention, and {TAIL ~ a pharmaceutically acceptable diluent} or carrier 
The invention further comprises a pharmaceutical composition comprising an antibody of the invention or an antigen binding fragment thereof , a nucleic acid molecule of the invention , or { HEAD ~ an immunogenic polypeptide } of the invention , and { TAIL ~ a pharmaceutically acceptable diluent } or carrier
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH